Chiome Bioscience Inc Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Chiome Bioscience Inc

Watchlist Manager

Watchlist

Price: 96 JPY -3.03% Market Closed

Market Cap: ¥7.7B

C	Chiome Bioscience Inc TSE:4583	JP
	Ratu Prabu Energi Tbk PT IDX:ARTI	ID
	Primerica Inc NYSE:PRI	US
	Verastem Inc F:2VSA	US
	Abcourt Mines Inc OTC:ABMBF	CA
P	Pacific Biosciences of California Inc F:P09	US
	Premia Finance SpA Societa di Mediazione Creditizia MIL:PFI	IT

Profitability Summary

Chiome Bioscience Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

58% > 61%

Negative Operating Margin

-148%

Negative 3Y Average Operating Margin

-160%

Operating Margin is Increasing

-156% > -148%

Negative Net Margin

-150%

Negative 3Y Average Net Margin

-160%

Net Margin is Increasing

-157% > -150%

Negative Free Cash Flow Margin

-137%

Negative 3Y Average Free Cash Flow Margin

-155%

Free Cash Flow Margin is Increasing

-156% > -137%

Negative ROE

-60%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-252%

ROIC is Increasing

-275% > -196%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

61%

Strong 3Y Average Gross Margin

57%

Gross Margin is Increasing

58% > 61%

Negative Operating Margin

-148%

Negative 3Y Average Operating Margin

-160%

Operating Margin is Increasing

-156% > -148%